SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitmine Immersion Technologies, Inc. is a technology company focused on acquiring, holding, and actively managing ETH as its primary treasury reserve asset. It prioritizes digital ecosystem services, such as consultancy and advisory works. The company was founded on August 16, 1995 and is headquartered in Las Vegas, NV.

BitMine Immersion Technologies Inc

Bitmine Immersion Technologies Inc

Bitmine Immersion Technologies is trending after its annual shareholder meeting, where a controversial vote to authorize 50 billion shares reportedly passed, alongside news of a $200 million equity investment in Mr. Beast's Beast Industries. The community is sharply divided, with many expressing concern over potential dilution and questioning the strategic value of the Mr. Beast deal, while others see it as a smart move for mainstream exposure, all against a backdrop of skepticism regarding CEO Tom Lee's credibility.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending following reports of robust early demand for its recently launched oral Wegovy pill, which is amplified by a regulatory delay for a key competitor's oral obesity treatment. This development gives Novo Nordisk a significant first-mover advantage in the burgeoning oral GLP-1 market, driving community discussion around the drug's "game-changing" potential and the company's strong growth prospects.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in West Palm Beach, FL.

Ondas Holdings Inc

The upcoming Investor Day for Ondas Holdings is generating significant buzz, with the community highly anticipating potential announcements regarding a major contract, updated 2026 financial outlook, and a rumored spin-off of its drone division, following a substantial $1 billion capital raise. Investors are keenly watching how this capital and strategic government tenders will impact the company's trajectory, fueling fervent debate between expectations of significant upside and concerns over market manipulation and "sell the news" events. Amidst geopolitical tensions highlighting demand for drone and defense technologies, discussions center on whether Ondas Autonomous Systems can deliver transformative news to solidify its position in the rapidly expanding sector.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending after being selected as an awardee for a significant defense contract, validating its innovative direct-to-smartphone satellite technology for both civilian and military applications. The community is actively celebrating the stock's recent surge past a key psychological price level, fueling widespread discussion about a potential short squeeze and its long-term disruptive potential in global telecommunications, despite ongoing debates about its valuation as a pre-revenue company.

Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Regentis Biomaterials Ltd.

Regentis Biomaterials

Regentis Biomaterials ($RGNT) is gaining significant attention due to its extremely low public float and a recently secured U.S. patent for its GelrinC liquid formulation, which many believe was initially overlooked. The community is actively discussing the stock's potential for a strong upward movement, driven by its limited tradable shares and insider lock-up, generating anticipation for increased volume and price action for this recent IPO.

Springview Holdings Ltd. engages in the design and construction of residential and commercial buildings. It involves new construction, reconstruction, alterations, and other general contracting services. The company was founded in 2002 and is headquartered in Singapore.

Springview Holdings Ltd - Ordinary Shares - Class A

Springview Holdings Ltd

Springview Holdings (SPHL) is trending after a massive surge, driven by news of its international expansion into solar-ready homes in Singapore. The community is actively discussing its low-float status and short-squeeze potential, drawing comparisons to other recent parabolic movers, with some traders reporting brokerage limitations on buying.

Moolec Science SA engages in the development and production of science-based food ingredients. Its products include pet food, animal feed, and dietary supplements. The company was founded by Gastón Paladini, Henk Hoogenkamp, and Martin Salinas in 2020 and is headquartered in George Town, Cayman Islands.

Moolec Science SA

Moolec Science (MLEC) is experiencing significant market attention following its recent reverse stock split, which drastically reduced its tradable share float. This has ignited community discussion positioning it as a speculative low-float play, with many drawing comparisons to other stocks that have seen explosive short squeezes. Traders are keenly watching its high volatility and the potential for rapid price movements should momentum and volume persist.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is seeing a surge in attention following multiple analyst upgrades and its established position as a critical national security space partner through major government defense contracts. The community is actively bullish, celebrating impressive gains and eagerly anticipating milestones like the Neutron rocket's maiden flight, even amidst ongoing discussions about its valuation in a rapidly expanding sector.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending due to robust Phase 2 data for its obesity drug VK2735 and heightened M&A speculation following Novo Nordisk's CEO expressing openness to multi-billion dollar acquisitions in the weight-loss sector. The community is actively debating VKTX's 

High Roller Technologies, Inc. is an evolving and growth-oriented iCasino and entertainment company, which engages in the business of operating an online gaming business offering casino betting games to customers. The firm also offers a wide range of games including many that are available in land-based casinos, such as blackjack, roulette, baccarat, poker, and slot machines. The company was founded by Michael Alexander Cribari and Brandon Christopher Eachus on December 21, 2021 and is headquartered in Las Vegas, NV.

High Roller Technologies Inc.

High Roller Technologies Inc

High Roller Technologies is trending due to recent announcements of strategic partnerships with crypto.com/us and lines.com, positioning the company to enter the rapidly expanding prediction markets space. The community is actively debating the stock's potential for significant upside, drawing comparisons to other high-volatility runners and fueling discussions around its low float and a potential short squeeze, amidst warnings about future offerings.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

What Makes Black Diamond (BDTX) a New Strong Buy Stock

Black Diamond (BDTX) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

New Strong Buy Stocks for January 9th

BDTX, LUMN, ADEA, ACRE and TACT have been added to the Zacks Rank #1 (Strong Buy) List on January 9th, 2026.

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX) Receives Average Recommendation of "Moderate Buy" from Brokerages

Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the eight brokerages that are currently covering the stock...

Shares of Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Get Free Report) have been given an average rating of "Moderate Buy" by the eight ratings firms that are presently covering the firm...

Black Diamond Therapeutics (NASDAQ:BDTX) Stock Rating Lowered by Guggenheim

Guggenheim downgraded Black Diamond Therapeutics from a "buy" rating to a "neutral" rating in a research report on Wednesday...

Down 30.5% in 4 Weeks, Here's Why You Should You Buy the Dip in Black Diamond (BDTX)

Black Diamond (BDTX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Is ANI Pharmaceuticals (ANIP) Stock Outpacing Its Medical Peers This Year?

Here is how ANI Pharmaceuticals (ANIP) and Black Diamond (BDTX) have performed compared to their sector so far this year.

Piper Sandler Initiates Coverage on Black Diamond Therapeutics (NASDAQ:BDTX)

Piper Sandler began coverage on shares of Black Diamond Therapeutics in a research note on Tuesday. They set an "overweight" rating and a $9.00 price objective on the stock...

What is HC Wainwright's Forecast for BDTX FY2025 Earnings?

Black Diamond Therapeutics, Inc. (NASDAQ:BDTX - Free Report) - Research analysts at HC Wainwright boosted their FY2025 EPS estimates for Black Diamond Therapeutics in a note issued to investors on...

Is ANI Pharmaceuticals (ANIP) Outperforming Other Medical Stocks This Year?

Black Diamond Therapeutics, Inc. is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. The company’s MasterKey therapies are designed to address a broad spectrum of genetically defined tumors, overcome resistance, minimize wild-type-mediated toxicities, and be brain-penetrant to treat central nervous system diseases. It is currently focused on advancing a Phase 2 NSCLC trial of BDTX-1535, a brain-penetrant, fourth-generation epidermal growth factor receptor (EGFR) MasterKey inhibitor targeting EGFR-mutant NSCLC and glioblastoma. The company was founded by David M. Epstein and Elizabeth Buck in 2014 and is headquartered in Cambridge, MA.

Black Diamond Therapeutics Inc

Short-Term Volatility, Then Markets Move On

Sustained Risk-Off Until Fed Path Is Clear

Little Impact — Fundamentals Still Rule

Other – Comment Below

Markets pulled back after reports that the DOJ opened a criminal investigation into Federal Reserve Chair Jerome Powell, raising concerns about central bank independence. With rate cuts, inflation, and political pressure all in focus, how do you think this standoff will impact markets in 2026?

How Will the Powell Investigation Impact Markets in 2026?

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.18	--	--	N/A
Q3 '25	-$0.23	-$0.15	35.98%	BEAT
Q2 '25	-$0.25	-$0.19	23.23%	BEAT
Q1 '25	$0.02	$0.98	4490.16%	BEAT
Q4 '24	-$0.31	-$0.28	11.02%	BEAT

BDTX
Black Diamond Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest BDTX News

BDTXBlack Diamond Therapeutics Inc